Price movement over the last 24 hours
Bio Protocol vs Syscoin — how do they compare? Bio Protocol trades at Rp524.44 (market cap Rp1,16T, Rp242,17M 24h volume), while Syscoin trades at Rp40.34 (market cap Rp53,96M, Rp18,57M 24h volume). The key difference: Bio Protocol is far larger — about 21497.4× Syscoin's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Syscoin's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Syscoin for 70 Days on average.
| BIO | SYS | |
|---|---|---|
Market Cap | Rp1,16T | Rp53,96M |
Volume (24h) | Rp242,17M | Rp18,57M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 889,7M SYS |
Typical Hold Time | 16 Days | 70 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
Syscoin shows limited market activity with a modest market cap of Rp53,96M and circulating supply of 889,7jt tokens. The asset demonstrates a relatively long average hold time of 70 days, suggesting some investor patience despite current low trading volumes. No recent protocol updates or significant ecosystem developments have been observed, indicating a period of stability without major catalysts.
Overall outlook remains cautious due to low liquidity and limited market presence. Key opportunities include potential network adoption growth, while major risks involve high volatility and regulatory uncertainty typical of smaller crypto assets. Investors should monitor for any upcoming protocol developments or exchange listings that could impact liquidity.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Syscoin Platform (SYS) is a full Layer-1 and Layer-2 blockchain solution built to combine industry-proven technology to support cutting-edge applications all in one network. The project's goal is to build a protocol that transforms the blockchain experience and combines the best of Bitcoin and Ethereum.
Read more on SYS →